Aimia Inc. (AIMFF)
| Market Cap | 177.58M +12.3% |
| Revenue (ttm) | 373.13M +5.0% |
| Net Income | 25.38M |
| EPS | 0.27 |
| Shares Out | n/a |
| PE Ratio | 7.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 101 |
| Average Volume | 14,639 |
| Open | 1.930 |
| Previous Close | 1.950 |
| Day's Range | 1.930 - 1.930 |
| 52-Week Range | 1.612 - 2.460 |
| Beta | 0.08 |
| RSI | 31.82 |
| Earnings Date | Mar 24, 2026 |
About Aimia
Aimia Inc. invests in public and private companies. It operates in three segments: Bozzetto, Cortland International, and Holdings. The company, through its long-term investments, provides specialty chemicals, textiles, and water and dispersion chemical solutions in various applications, including textile, home and personal care, plasterboard, and agrochemical markets; manufactures synthetic fiber ropes, as well as offers netting solutions for maritime and other industrial customers; and manufactures and supplies ropes, slings, and tethers for a... [Read more]
News
Aimia Inc (AIMFF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...
Aimia Inc (AIMFF) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on Opportunities
Q4 2025 Aimia Inc Earnings Call Transcript
Q4 2025 Aimia Inc Earnings Call Transcript
Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript
Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript
AIMIA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
TORONTO , March 24, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) ("Aimia" or the "Company"), today reported its financial results for the three-month period and full year ended December 31, 2025. Al...
AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress
OCALA, Fla. — Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million share...
Why Is AIM ImmunoTech Stock Gaining Today?
AIM ImmunoTech Inc. (AMEX: AIM) shares moved higher on Wednesday after the company secured full approval for a key cancer-related patent in Japan. • AIM ImmunoTech stock is showing exceptional streng...
AIM ImmunoTech Gains Japanese Patent Approval for Cancer Treatment
AIM ImmunoTech Gains Japanese Patent Approval for Cancer Treatment
AIMIA DECLARES PREFERRED SHARE DIVIDENDS
TORONTO , March 16, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) today announced that its Board of Directors has declared quarterly dividends on each series of its preferred shares: A quarterly divi...
Verdict parent company GlobalData moves to Main Market of LSE
The move to the LSE's Main Market from the AIM reflects the scale and maturity achieved through GlobalData’s long-term strategy. The post Verdict parent company GlobalData moves to Main Market of LSE ...
AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer
AIM Collaborates with Thermo Fisher for Phase 3 Trial of Ampligen in Pancreatic Cancer
AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS
TORONTO , March 2, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) announced that it repurchased and settled for cancellation a total of 107,800 of its common shares in the month of February 2026 under...
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: AIM) ("AIM" or the "Company") today announced milestones in the expected timeline for the ongoing Phase 2 clinical study eval...
AIMIA ANNOUNCES DUAL LISTING ON JOHANNESBURG STOCK EXCHANGE
TORONTO , Feb. 17, 2026 /CNW/ - Aimia Inc. (TSX: AIM) ("the Company") announced today the dual listing of its common shares on the Main Board of the Johannesburg Stock Exchange (" JSE ") effective Fe...
IHG revenues up, ITM Power upgrades outlook and Debenhams funding round
Plus we have updates from AIM listed Helium One and Cambridge Cognition - and we turn our attention to German stocks for our Plus+ members
Aimia Inc. (AIM:CA) M&A Call Transcript
Aimia Inc. (AIM:CA) M&A Call Transcript
Aimia Inc. (AIM:CA) Q3 2025 Earnings Call Transcript
Aimia Inc. ( AIM:CA) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Joseph Racanelli - Vice President of Investor Relations & Communications Rhys Summerton - Executive Chair...
Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript
Aimia Inc. (AIMFF) Q2 2025 Earnings Call Transcript
Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Rhys Summerton - Executive Chairman Steven L...
Aimia Inc. (AIMFF) Q4 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q4 2024 Results Conference Call March 28, 2025 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Rhys Summert...
Aimia Inc. (AIMFF) Q3 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Joe Racanelli - Vice President of Investor Relations Tom Finke - Executive Chairman Steve Leo...
Aimia Inc. (AIMFF) Q2 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Joe Racanelli - Investor Relations Tom Finke - Executive Chairman Steve Leonard - President & ...
Aimia Inc. (AIMFF) Q1 2024 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Joe Racanelli - VP, IR and Communications Tom Finke - Executive Chairman Steve Leonard - Chief Fin...
Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript
Aimia Inc. (AIMFF) Q4 2023 Earnings Call Transcript
Aimia, Inc. (AIMFF) Q3 2023 Earnings Call Transcript
Aimia, Inc. (OTCPK:AIMFF) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Albert Matousek - IR Phil Mittleman - CEO Michael Lehmann - President Steve Leonard - CFO C...
Aimia Inc. (AIMFF) Q2 2023 Earnings Call Transcript
Aimia Inc. (OTCPK:AIMFF) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET Company Participants Albert Matousek - Head of Investor Relations and Communications Phil Mittleman - Chief Executi...